Boston Scientific (BSX) Interest Expenses (2009 - 2026)

Boston Scientific (BSX) has 18 years of Interest Expenses data on file, last reported at $512.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 524.39% year-over-year to $512.0 million; the trailing twelve-month figure through Mar 2026 stood at $512.0 million (up 61.01% YoY), and the FY2025 full-year result was $786.0 million, down 38.01% from the prior year.
• Interest Expenses improved to $512.0 million in Q1 2026, from $90.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $512.0 million in Q1 2026 to a low of $44.0 million in Q4 2022.
• A 5-year average of $131.7 million and a median of $77.0 million in 2024 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 76.7% in 2023 and surged 524.39% in 2026, its largest moves.
• Tracing BSX's Interest Expenses over 5 years: stood at $44.0 million in 2022, then soared by 47.73% to $65.0 million in 2023, then increased by 23.08% to $80.0 million in 2024, then advanced by 12.5% to $90.0 million in 2025, then jumped by 468.89% to $512.0 million in 2026.
• Business Quant data shows BSX's Interest Expenses at $512.0 million in Q1 2026, $90.0 million in Q4 2025, and $87.0 million in Q3 2025.